Boostrix And Adacel Get Universal Recommendation For 11-12 Year-Olds
This article was originally published in The Pink Sheet Daily
Executive Summary
CDC’s Advisory Committee on Immunization Practices also recommends catch-up Tdap vaccination for adolescents who have already received a Td booster. ACIP further recommends concomitant administration of Tdap with Sanofi-Aventis’ meningococcal conjugate vaccine Menactra.
You may also be interested in...
Sanofi-Aventis' Adacel Launch Plans Await CDC Recommendations
FDA clears the tetanus, diphtheria, pertussis booster vaccine for individuals ages 11-64. Phase IV commitments include a concomitant use study with Sanofi's meningococcal vaccine Menactra.
GSK May Launch Boostrix Vaccine Ahead Of June CDC Recommendation
The tetanus, diphtheria and pertussis vaccine clears FDA for patients ages 10 through 18. The vaccine approval follows the advisory committee's 13-0 unanimous recommendation in favor of use in that population, as well as its recommendation for a postmarketing trial.
NME Slowdown Shows Market Pressure On Me-Toos, Not FDA Caution – Lutter
DURHAM, N.C. - The decline in FDA's tally of new molecular entity approvals stems from fewer approvals of non-innovative products in recent years, while approvals of truly innovative products has largely held steady, according to FDA Deputy Commissioner for Policy, Planning and Preparedness Randall Lutter